Up-regulation of FCN3, ApoE, ApoA1, ApoA4, AMBP, ACTB, CATA, AFAM, CLUS, and CERU proteins has also been observed in aggressive B-ALL patients (60). This evidence concerns the gene APOA1 and precursor B-cell acute lymphoblastic leukemia.